Aspire Private Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-19
Closed -$3.73K 688
2024
Q2
$3.73K Hold
19
﹤0.01% 496
2024
Q1
$4.09K Hold
19
﹤0.01% 509
2023
Q4
$4K Buy
+19
New +$4.05K ﹤0.01% 500
2021
Q3
Sell
-1
Closed 600
2021
Q2
$0 Hold
1
﹤0.01% 587
2021
Q1
$0 Sell
1
-2
-67% -$394 ﹤0.01% 543
2020
Q4
$1K Buy
3
+1
+50% +$170 ﹤0.01% 409
2020
Q3
$0 Sell
2
-58
-97% -$9.77K ﹤0.01% 467
2020
Q2
$9K Buy
60
+57
+1,900% +$10.2K ﹤0.01% 214
2020
Q1
$1K Sell
3
-11
-79% -$2.19K ﹤0.01% 202
2019
Q4
$3K Hold
14
﹤0.01% 341
2019
Q3
$3K Hold
14
﹤0.01% 317
2019
Q2
$3K Buy
+14
New +$2.58K ﹤0.01% 353

Other funds holding CME

Aspire Private Capital's CME Position: Q3 2024 in Review

Aspire Private Capital sold out of CME Group (CME) in Q3 2024, closing a stake of 19 shares — an estimated $3.73K sold.

Aspire Private Capital first reported a position in CME in Q2 2019 and held it in 12 quarters. The position peaked at $9K in Q2 2020. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • Aspire Private Capital reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
  • Aspire Private Capital sold 19 CME Group shares in Q3 2024, an estimated $3.73K.
  • Aspire Private Capital first reported a position in CME Group in Q2 2019 and held it in 12 quarters.
  • Aspire Private Capital's CME Group position peaked at $9K in Q2 2020.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Aspire Private Capital's 13F filing for Q3 2024, filed 25 Oct 2024.